Sandbox g16
Dosage adjustment in patients with hepatic disease Return to Top
Dosage adjustment may be required in the presence of hepatic disease for the following medications (consult FDA package insert for details):
| Antimicrobial Agent | Category | Recommendation |
|---|---|---|
| ||
| Atazanavir | ||
| Caspofungin | ||
| Ceftriaxone | ||
| Chloramphenicol | ||
| Clindamycin | ||
| Darunavir | ||
| Delavirdine | ||
| Efavirenz | ||
| Enfuvirtide | ||
| Fosamprenavir | ||
| Fusidic acid | ||
| Indinavir | ||
| Isoniazid | ||
| Itraconazole | ||
| Lopinavir-Ritonavir | ||
| Metronidazole | ||
| Nafcillin | ||
| Nelfinavir | ||
| Nevirapine | ||
| Quinupristin-Dalfopristin | ||
| Rifabutin | ||
| Rifampin | ||
| Rimantadine | ||
| Ritonavir | ||
| Telithromycin | ||
| Tigecycline | ||
| Tinidazole | ||
| Voriconazole |